Back to search results

TELESCOPE Coaching for Lung Cancer Screening in Hispanic Individuals

This study, called TELESCOPE, is testing a coaching program designed to help Hispanic individuals decide about and get screened for lung cancer. The program includes a decision aid, coaching, referrals to smoking cessation services, and help navigating the screening process. We want to see if this program is easy to use and helpful for Hispanic people who smoke or used to smoke. To join, you must be Hispanic, between 50 and 77 years old, and have a history of smoking at least 20 pack-years. The study aims to recruit about 91 participants and will measure how many people join, how much they like the program, and how many complete their follow-up.

Study design
This is an interventional pilot feasibility trial with about 91 participants. It aims to adapt an existing program for Hispanic individuals and then test its feasibility and acceptability.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 1 week after the intervention to measure recruitment rate, acceptability, and follow-up completion rate.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07165691

TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary Care (TELESCOPE) for Hispanics

Recruiting
NAAges 50–77InterventionalScreening
Rutgers, The State University of New Jersey
~91 participants
Updated 2025-12-02 on ClinicalTrials.gov
What's tested:TELESCOPE, Remote Decision Coaching with Navigation Intervention

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Recruitment rate
Measured over 1 week post-intervention
+3 more outcomes measured

Conditions

Lung Neoplasms

Explore related trials

Lung Carcinoma

Where it's being run

1 sites across 1 states
New Jersey1

Study leadership

  • Evelyn Arana, DrPH · PRINCIPAL_INVESTIGATOR · Rutgers Cancer Institute of NJ

Who to contact

Evelyn Arana, DrPH
[email protected]
9086420861
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Identify as Hispanic or Latino(a)
Able to speak and read in English or Spanish
Be 50 to 77 years of age
Be a current or former smoker having quit within the past 15 years
Have at least a 20 pack-year smoking history
Be scheduled for a non-acute care visit at one of the study sites.
Not coughing up blood in the last two weeks
A practicing primary care clinician or a clinic director (n=20), nursing director, or clinic practice administrator at one of the participating sites, or a TELESCOPE study patient navigator and nurse navigator
Age 18 or older
Fluent in English
A practicing primary care provider at one of the participating sites or a TELESCOPE study navigator
Age 18 or older
Fluent in English

Exclusion

Do not speak English
Are not Hispanic or Latino(a)
Have a history of lung cancer
Had a CT scan in the past 12 months
Has been coughing up blood in the last two weeks
Have health conditions that make them poor candidates for curative treatment as determined by the primary care provider,
Are unable to provide informed consent Interviews
Are unable to provide informed consent Online surveys
Are unable to provide informed consent
Women who are pregnant.

What this trial measures

  • Recruitment rate1 week post-intervention

    The investigators expect a recruitment rate of ≥60%.

  • Participant Acceptability1 week post-intervention

    The Ottawa Acceptability Measure will assess the acceptability of the TELESCOPE intervention from the patient's perspective at 1-week post-intervention. There is no total score for this measure. Responses will be reported descriptively in terms of proportions responding positively or negatively for each criteria.

  • Follow-up completion rate1 week post-intervention

    The investigators expect that ≥90% of Hispanic participants will complete the 1-week follow-up assessments

  • Intervention Fidelity Rate1 week post-intervention

    The investigators expect that ≥80% of the key intervention components will be delivered with 80% fidelity by the patient navigators.